Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis (Translation: The University of Toledo Journal of Medical Sciences, 2025)
Keywords: MASLD; MASH; Pemafibrate; PPARS; Lipid profile; Liver fibrosis; Liver stiffness